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This study was planned to observe the clinical and radiological course of single small enhancing CT lesions in Indian patients
presenting with new-onset-seizures. In this study, 75 patients with new-onset seizures and a single enhancing CT lesion were
prospectively followed up for 1 year. All patients fulfilled the criteria of cysticercus granuloma. The repeat CT scans were
performed 2 months after the first CT scan. Antiepileptic drug therapy was the only form of treatment given. The majority
of patients were below 20 years of age. Simple partial seizure, with or without secondary generalization, was the commonest
type of seizure encountered in these patients. In follow-up CT scans 84% of patients showed either disappearance or regression
in the size of lesion. The proportion of patients showing complete disappearance of CT lesions was 0.73 (95% CI, 0.61–
0.80). In 11 (15%) patients the lesions were calcified. In nine patients, in whom the lesion had persisted or regressed, another
follow-up CT scan (6 months after the second scan) revealed either complete disappearance or calcification of the lesions. The
majority (86.6%) of patients remained seizure free for 1 year after starting antiepileptic drugs. Ten patients experienced seizure
recurrences within the first month of therapy. The proportion of patients who remained seizure free was 0.86 (95% CI, 0.76–
0.92). Four patients experienced seizure recurrence even after complete disappearance of CT lesions. In the majority of patients
the lesions disappeared spontaneously and in a few the lesions calcified; hence these patients did not require anticysticercal
therapy. Antiepileptic therapy was helpful in controlling further recurrences of seizures in most of the patients. A few patients
experienced seizures even after disappearance of CT lesions.
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INTRODUCTION
Single enhancing CT lesions (Fig. 1) are a common
imaging abnormality in Indian patients with new-
onset seizures1–4. Histopathological studies5 suggest
that single enhancing CT lesions, in the majority of
patients, represent dying cysticercus larva. Another,
less common, cause of these lesions are tuberculomas.
Several retrospective studies have observed that
these lesions resolve spontaneously3, 6. In several
other studies7–9 these lesions have been treated
with anticysticercal drugs, however, with conflicting
results. The objective of the present study was to
prospectively observe the clinical and radiological
course in these patients.
MATERIALS AND METHODS
This prospective study included 75 consecutive
patients of new-onset seizure disorder with a con-
trast CT scan showing a ring/disc-enhancing lesion.
These patients were attending Neurology/Medicine
outdoor clinics of Sir Sunder Lal Hospital, Institute
of Medical Sciences, Banaras Hindu University,
Varanasi, India, between July 1997 and February
1999. All these patients presented within 7 days
of onset of seizure disorder and were immediately
(within 48 hours) subjected to plain and contrast
CT scans. The patients selected fulfilled the clinical
and radiological criteria suggestive of cysticercus
granuloma10 (Table 1).
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Fig. 1: Plain and contrast-enhanced cranial computed tomography showing a ring enhancing CT lesion along with perifocal
oedema.
Table 1: Diagnostic criteria for cysticercus granuloma10.
Clinical criteria
1. Seizures (partial or generalized) should be the initial symptom.
2. There should no features of persistent raised intracranial
pressure.
3. There should be no history of progressive neurological deficit.
4. There should be no evidence of active systemic disease.
CT criteria
1. CT scan should only show a solitary, contrast-enhancing lesion.
2. The lesion should measure less than 20 mm in maximal
dimension.
3. Oedema may or may not be present, but is not severe enough to
produce a shift of midline structures.
PATIENT’S EVALUATION
Each selected patient was subjected to a detailed
neurological examination. An eyewitness account of
seizure episodes was obtained either from a relative
or a friend. Seizures were classified as per the
International League Against Epilepsy Classification
of seizure types. In each patient, routine haemato-
logical and biochemical parameters were obtained.
In addition, enzyme-linked immunosorbent assay
(ELISA) for human immunodeficiency virus (e.g.
toxoplasmosis) and chest X-ray (e.g. secondary metas-
tasis) were performed to exclude other possible causes
of similar CT morphology. A 21-channel electroen-
cephalography was also performed in each patient.
In 60 patients in vitro qualitative determinations
of anti Taenia solium antibodies in serum were
performed by using solid- phase ELISA employing
plastic wells coated with Taenia solium antigen. Forty
healthy age matched controls were also subjected
to ELISA for Taenia solium antibodies. The results
were classified as positive and negative. Positive
specimens yielded optical density absorbency readings
greater than 1.404 at the 450 nm wavelength of the
photometric well reader (package insert).
TREATMENT AND FOLLOW-UP
In all patients antiepileptic drugs were started
immediately. Patients were given monotherapy, and
the antiepileptic drug administered was either carba-
mazepine or phenytoin (Table 1). Initial drug dosage
was based on body weights. In situations of seizure
recurrence and/or respective antiepileptic drug toxic-
ity, appropriate dosage adjustments were performed.
Therapeutic drug monitoring of antiepileptic drugs
was not done. None of the patients was treated with
anticysticercal treatment.
Patients were followed up at fortnightly intervals for
the first 2 months, and then, at intervals of 3 months,
patients were prospectively followed up for a total of
1 year. Follow-up CT scans were performed 8 weeks
after the initial CT scan. Visual analyses of CT scans
were performed by an independent observer (a radiol-
ogist who was not familiar with the clinical status of
the patients). The lesion was considered ‘persisting’
if no change in the CT appearance of the lesion was
noted. It was considered as ‘regressing’ if, on visual
analysis, the amount of cerebral oedema had reduced
and/or the morphology of the lesion had altered. The
’disappearance’ of the lesion was considered when
the follow-up CT scan was reported as normal. The
lesions were considered ‘calcified’ when a hyperdense
lesion was seen on a plain CT scan at the same place
where the original enhancing lesion was situated. In
patients in whom the enhancing CT lesions did not
disappear at 2 months, another follow- up scan was
obtained after 6 months of further follow-up.
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Table 2: Clinical characteristics of patients with single
enhancing CT lesions and seizures (n = 75).
1. Age (year)
Mean 15.46± 7.73
< 10 20 (26.6%)
10–20 45 (60.0%)
> 20 10 (13.3%)
2. Sex
Male 45 (60.0%)
Female 30 (40.0%)
3. Mean duration of illness (days) (mean ± SD) 8± 3.5
4. Seizure patterns
Single seizure 5 (6.6%)
Seizures in clusters 57 (76.0%)
Recurrent seizures 10 (13.3%)
Status epilepticus 3 (4.0%)
5. Todd’s palsy 6 (8.0%)
6. Mean of number of seizures before start of 3.9± 3.5
treatment (mean ± SD)
7. Antiepileptic drugs given as monotherapy
Carbamazepine 61 (81.3%)
Phenytoin 14 (18.6%)
8. Electroencephalography
Normal 57 (76.0%)
Generalized slowing 4 (5.3%)
Focal slowing 10 (13.3%)
Focal spikes 4 (5.3%)
STATISTICAL ANALYSIS
The follow-up observations were also presented in
proportions and one sample z-test for proportion was
used to analyse the level of significance. Wherever
required the data were also analysed by using a chi-
squared test, and a P value < 0.01 was considered
significant.
RESULTS
There were 75 patients who fulfilled the inclusion
criteria during the study period. The majority of
patients (86.6%) were 20 or less years of age.
The male and female ratio was 3 : 2 (Table 2).
Simple partial seizures with or without secondary
generalization were the commonest type of seizures
(69.3%) associated with single enhancing CT lesions
(Table 3). In 76% of the patients seizures occurred
in clusters (multiple seizures within 24 hours), only
10 patients reported recurrent seizures before the
start of antiepileptic therapy (Table 2). Routine
electroencephalography was found to be unrewarding
and was normal in 76% of the patients. A significantly
higher number of patients (P< 0.01) had a positive
ELISA test for anti Taenia solium antibodies in
comparison to controls. The sensitivity and specificity
of the ELISA test was 60% and 72.5%, respectively
(Table 4).
Table 3: Various seizure types seen in patients with single
enhancing CT lesions (n = 75).
Seizure types No. %
Simple partial 25 33.3
Simple partial with secondary generalization 27 36.0
Complex partial 5 6.6
Complex partial with secondary generalization 1 1.3
Generalized tonic–clonic 17 22.6
Table 4: Positive ELISA test for anti Taenia solium antibodies
in patients with seizures and single enhancing CT lesions,
and controls.
No. %
Patients (n = 60) 36 60.0
(x2 = 15.35, P ≤ 0.01)
Controls (n = 40) 11 27.5
In the first CT scans, in approximately 10.6% of
the patients, an enhancing eccentric dot-like structure
suggestive of scolex of cysticercus larva was also seen
inside the ring lesions (Fig. 1). In 9.3% of the patients,
the lesions were disc enhancing.
Table 5: Incidence of various imaging abnormalities in
patients with single enhancing CT lesion (n = 75).
No. %
Type of lesion
A. Ring enhancing 68 90.6
without eccentric dot 60 80.0
with eccentric dot 8 10.6
B. Disk enhancing 7 9.3
Amount of oedema
Absent 27 36.0
Mild 39 52.0
Moderate 7 9.3
Severe 2 2.6
Location of lesions
Frontal 9 12.0
Fronto-parietal 5 6.6
Parietal 42 56.0
Parieto-occipital 11 14.6
Occipital 4 5.3
Temporal 2 2.6
Parasagittal 2 2.6
Single enhancing CT lesions were more common
in posterior parietal regions. In 76% of patients these
lesions were in parietal and occipital regions. In
two patients lesions were present in the parasagittal
region, both patients had post-ictal Todd’s palsy,
weakness was more marked in the lower limbs of these
patients. Approximately half of the patients had mild
oedema (restricted to the cerebral lobe involved). Only
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two patients had severe cerebral oedema (producing
midline shift). Seven (9.3%) patients had moderate
oedema (oedema involving the adjacent cerebral lobe)
(Table 5).
Follow-up CT scans performed 2 months after the
initial CT scan showed either complete disappearance
(Fig. 2) or regression in the size of the lesions
in the majority (84%) of patients. The proportion
of patients showing complete disappearance of CT
lesions (follow-up CT scans were normal) was 0.73
(95% CI, 0.61–0.82, P =< 0.01). Lesions were
calcified in 11 (14.6%) patients (Fig. 3). In only
one patient the lesion remained unchanged (Table 6).
Of nine patients in whom the lesion had persisted,
or regressed, a repeat CT scan 6 months later
showed complete disappearance in six patients and
calcification of the lesion in three patients.
Table 6: Changes seen in follow-up CT scans after two
months (n = 75).
Changes in lesions No. %
A. Disappeareda 55 73.3 (P ≤ 0.01)
B. Not disappearedb 20 26.6
calcified 11 14.6
regressed 8 10.6
unchanged 1 1.3
a Normal follow-up CT scan; b abnormal follow-up CT scan.
Table 7: Seizure recurrence in patients with single enhancing
CT lesion after starting antiepileptic drugs during the 1 year
follow-up (n = 75).
No. %
A. Patients with no recurrence 65 86.6 (P =< 0.01)
B. Patients with recurrence 10 13.3
No. of recurrences
1–3 7 70.0
4–6 2 20.0
> 6 1 10.0
Time of first recurrence
During first month 8 80.0
After 6 months 2 20.0
Correlation with CT findings
Normal CT 4 40.0
Abnormal CTa 6 60.0
a Persistence or regression or calcification of CT lesions.
The proportion of patients who did not experience
another seizure after starting antiepileptic therapy
until completion of 1 year of treatment was 0.86
(95% CI, 0.76–0.92, P =< 0.01). Only 10 patients
experienced seizure recurrence during the follow-up
period of 1 year. Most of the patients (who had seizure
recurrence) experienced their first recurrence within
1 month of follow-up. Four patients experienced
seizure recurrence despite complete disappearance of
CT lesions (Table 7).
DISCUSSION
In this study, we observed that single enhancing CT
lesions frequently affected younger patients; these
patients presented as acute new-onset seizure disorder.
Simple partial seizures with or without secondary
generalization are the commonest seizure type seen in
these patients irrespective of location of CT lesions.
We also observed that the seizures tended to occur in
clusters.
In the brain, a cysticercal cyst passes through four
stages in its natural evolution. In the ‘vesicular’
stage the viable cyst contains invaginated larva bathed
in translucent fluid. The cyst is encapsulated and
there is little tissue reaction. On CT the ‘vesicular’
form of cysticercosis appears as a non-enhancing
lesion without oedema. Eventually, in circumscribed
and hypodense response to the host’s immune
reaction against the parasite the cyst shows hyaline
degeneration and early mineralization. The cysts fluid
changes to whitish, jelly-like material and the capsular
membrane thickens. Inflammatory changes develop in
the cyst wall and surrounding brain parenchyma. This
‘colloidal’ stage produces on CT a ring-enhancing
lesion, initially with perilesional vesogenic oedema.
As the lesion continues to regress, the cyst size is
reduced and the cyst membrane further thickens. The
cyst contents are transformed into coarse granules,
due to mineralization with calcium salt. This is
the ‘granular-nodular’ stage, which is seen as a
disc-enhancing lesion in CT scans. Ultimately the
cyst becomes completely mineralized—the ‘calcified
stage’—and a nodular hyperdense lesion is seen
in non-contrast CT scans11, 12. Patients having a
parenchymal cysticercal lesion become symptomatic
when the cyst becomes acutely inflamed and this
results in seizure clusters and frequent early recur-
rences. With resolution of inflammation in and around
cystic lesions, the possibility of seizure recurrence
also decreases. Murthy and Subha Reddy13 in their
recent article observed that in the majority of patients
seizures do not recur, even after withdrawing the
antiepileptic drug, after the lesion has disappeared.
In our study we could not confirm this observation.
However, four patients experienced seizure recurrence
even after complete resolution of the CT lesions.
Possibly, focal cerebral gliosis, as a result of healing
the inflammatory lesion, can also have epileptogenic
potential. In a retrospective study by Murthy et al.14
similar findings were observed. Seizures did not recur
in 162 (61.8%) of 262 patients with single enhancing
CT lesions after initiation of antiepileptic therapy.
Seventy-four patients continued to have seizures for
some time (median, 2 months) before remission. In
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Fig. 2: (a) A ring enhancing CT lesion with eccentric scolex; (b) follow-up scan after 2 months showing complete disappearance
of the lesion and oedema.
Fig. 3: (a) Ring enhancing CT lesion; (b) plain CT scan after 2 months showing calcification of the same lesion.
the remaining 26 (10%) patients seizures continued to
recur (median, 8 months), and seizure remission was
achieved following cysticercal therapy. Antiepileptic
drugs were discontinued in 206 patients after a
seizure-free period of ≥2 years. In all these patients
the CT lesions had resolved on follow-up CT scans. In
this study14 only two patients experienced recurrence
of seizures. In one of these patients, the repeat CT scan
showed a gliotic scar at the site of previous lesion. The
mean follow-up period was 31.4 months (range 14–
73 months).
Initially tuberculomas were considered as a possible
cause of single enhancing CT lesions1, at present it
is believed that tuberculosis is the cause only in a
minority of patients10. Moreover, tuberculomas are
very unlikely to resolve spontaneously.
There is enough evidence to suggest that anti-
cysticercal drugs (praziquantel and albendazole) are
of value in the management of active parenchymal
cerebral cysticercosis12. However, there are con-
flicting views7, 9 about the role of anticysticercal
drugs in the management of single enhancing CT
lesions. Our study clearly suggests that in the majority
of patients these lesions disappear spontaneously
within 2 months of the onset of seizure disorder.
Therefore, these patients do not require administration
of anticysticercal drugs.
Rajshekhar recommended anticysticercal drugs for
lesions that persisted in follow-up CT scans even after
12 weeks. Our study further suggests that even these
patients do not require any treatment because many of
the persisting lesions (if they do not disappear), as per
Escobar’s stages of natural evolution, are destined to
become calcified.
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In conclusion, the observations from our study
suggest that single enhancing CT lesions in patients
with new-onset seizures are benign in nature and
tend to disappear spontaneously within 2 months.
Antiepileptic monotherapy is effective in controlling
the seizures and recurrences are infrequent. A few
patients may experience seizure recurrence even after
disappearance of the CT lesions.
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